RIBOMIC enters license agreement with AJU Pharma for RBM-007 in age-related macular degeneration

RIBOMIC enters license agreement with AJU Pharma for RBM-007 in age-related macular degeneration. (Credit: Adam Radosavljevic from Pixabay)